Vesynta

Vesynta is a precision medicine company spun out from University College London (UCL) that specializes in data-guided dosing to personalize treatments, with a primary focus on pediatric oncology. The company develops an integrated platform consisting of the DosoLogic AI-driven software and the ChromaDose bedside monitoring device to measure and simulate drug exposure in real-time. By replacing traditional 'one-size-fits-all' dosing based on body surface area with individualized pharmacokinetic models, Vesynta aims to improve the safety and efficacy of chemotherapy, particularly for vulnerable populations. The company is currently collaborating with leading UK institutions like the Institute of Cancer Research and Great Ormond Street Hospital to validate its technology in clinical settings. Vesynta's mission is to democratize precision dosing and establish it as the standard of care across various therapeutic areas, including oncology and infectious diseases.